Physician profile
Brian E Mcgrath
NPI 1801862776
$136,053.86
in general payments reported to CMS, 2019-2025
16 companies · $4,166 in 2025
The $4,166 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $8,112 · 2021: $30K · 2022: $52K · 2023: $25K · 2024: $3,663 · 2025: $4,166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $6,797 · Travel and Lodging: $5,921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,075.63 |
| Food and Beverage | $6,797.19 |
| Travel and Lodging | $5,920.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $119,732.44 | 2019-2025 | Journey II, Real Intelligence, Redapt |
| Stryker Corporation | $9,896.90 | 2019-2025 | Chromophare F300, Mako, 1688 |
| Prodigy Surgical Distribution, INC. | $2,987.87 | 2021-2025 | |
| Zimmer Biomet Holdings, INC. | $2,596.46 | 2022-2025 | Arcos, Persona, Hammr Curved G7 Impactor |
| Depuy Synthes Sales INC. | $233.25 | 2024-2025 | |
| Avanos Medical | $158.44 | 2019-2023 | Grpro 2.1 |
| Medical Device Business Services, INC. | $114.43 | 2025 | Emphasys |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Baxter Healthcare | $50.76 | 2022-2023 | Hillrom - Helion Integrated Surgical System |
| Boston Scientific Corporation | $47.29 | 2023-2024 | Ekosonic, Eluvia |
| Globus Medical, INC. | $46.67 | 2024 | Affirm |
| Pacira Therapeutics, INC. | $43.79 | 2021 | |
| Abbott Laboratories | $22.38 | 2025 | Axium |
| Vertex Pharmaceuticals Incorporated | $22.29 | 2025 | |
| Bioventus LLC | $20.44 | 2023 | Durolane |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $18.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Mcgrath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.